New Imaging Procedures and Therapeutic Approach in Basal Cell Carcinoma Management
NCT ID: NCT05324202
Last Updated: 2022-04-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
50 participants
INTERVENTIONAL
2022-09-01
2023-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Randomized Pilot Study of Treatment for BCC Using the Multiplex 595/1064 nm Laser
NCT02270645
Long-pulsed 1064 nm Nd:YAG Laser Treatment of Basal Cell Carcinoma
NCT02662244
Use of Jet-injection in Photodynamic Therapy for Basal Cell Carcinoma
NCT04552990
Treating Basal and Squamous Cell Carcinomas With Fractional Laser and Tirbanibulin Ointment
NCT07010692
Optimizing Photodynamic Therapy of Cutaneous Neoplastic Diseases Via Structured Illumination and Real-time Dosimetry.
NCT00784108
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Nd:YAG treatment arm
Cynosure Cynergy Nd:YAG Laser 1064nm
The Nd:YAG Laser 1064nm is intended to be used as a treatment option in individuals suffering from low-risk basal cell carcinoma(s).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cynosure Cynergy Nd:YAG Laser 1064nm
The Nd:YAG Laser 1064nm is intended to be used as a treatment option in individuals suffering from low-risk basal cell carcinoma(s).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosed clinically, with a dermatoscope and through noninvasive imaging methods such as reflectance confocal microscopy and optical coherence tomography
* H zone \<6mm, M zone \<10mm, L zone \<20mm
* Tumor thickness \<2mm
* Clearly visible margins
Exclusion Criteria
* \<18 years of age
* Current or history of immunosuppression
* Prior-treatment of the basal cell carcinoma/ recurrent basal cell carcinomas
* History of radiation in the area of basal cell carcinoma appearance
18 Years
100 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Dr. Stephanie Geisler
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Stephanie Geisler
Investigator, Resident in Dermatology
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Ndyag_BCC_1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.